134 related articles for article (PubMed ID: 3523065)
21. Do generics offer significant savings to the UK National Health Service?
Kanavos P
Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
[TBL] [Abstract][Full Text] [Related]
22. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
[TBL] [Abstract][Full Text] [Related]
23. Medicaid prescription drug coverage: state efforts to control costs.
Gencarelli DM
NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
[TBL] [Abstract][Full Text] [Related]
24. Factors influencing the delivery of pharmacy services.
Miller MJ; Ortmeier BG
Am Pharm; 1995 Jan; NS35(1):39-45. PubMed ID: 7887373
[TBL] [Abstract][Full Text] [Related]
25. Reform of prescription drug reimbursement and pricing in the German social health insurance market: a comparison of three scenarios.
Gress S; Niebuhr D; May U; Wasem J
Pharmacoeconomics; 2007; 25(6):443-54. PubMed ID: 17523750
[TBL] [Abstract][Full Text] [Related]
26. Incentives and pharmaceutical reimbursement reforms in Spain.
Puig-Junoy J
Health Policy; 2004 Feb; 67(2):149-65. PubMed ID: 14720633
[TBL] [Abstract][Full Text] [Related]
27. Cost and price of comparable branded and generic pharmaceuticals.
Bloom BS; Wierz DJ; Pauly MV
JAMA; 1986 Nov; 256(18):2523-30. PubMed ID: 3773152
[TBL] [Abstract][Full Text] [Related]
28. Copayment for pharmaceutical services in a Medicaid program.
Nelson AA; Quick MR
Contemp Pharm Pract; 1980; 3(1):37-42. PubMed ID: 10297666
[TBL] [Abstract][Full Text] [Related]
29. Growing pains. Insurers and PbMs want in on 340B savings.
Lee J
Mod Healthc; 2012 Mar; 42(11):10. PubMed ID: 22462315
[No Abstract] [Full Text] [Related]
30. Abandoning List Prices In Medicaid Drug Reimbursement Did Not Affect Spending.
Ippolito B; Levy JF; Anderson GF
Health Aff (Millwood); 2020 Jul; 39(7):1202-1209. PubMed ID: 32634350
[TBL] [Abstract][Full Text] [Related]
31. Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?
Kanavos P; Taylor D
Curr Med Res Opin; 2007 Oct; 23(10):2467-76. PubMed ID: 17764613
[TBL] [Abstract][Full Text] [Related]
32. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
[No Abstract] [Full Text] [Related]
33. Negotiating with third party payers: one community pharmacy's experience.
Fridy K; DeHart RM; Monk-Tutor MR
J Am Pharm Assoc (Wash); 2002; 42(5):780-8. PubMed ID: 12269712
[TBL] [Abstract][Full Text] [Related]
34. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
Smith DH; Fassett WE; Christensen DB
J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
[TBL] [Abstract][Full Text] [Related]
35. Differences in the cost of antidepressants across state Medicaid programs.
Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
[TBL] [Abstract][Full Text] [Related]
36. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
Academy of Managed Care Pharmacy
J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
[TBL] [Abstract][Full Text] [Related]
37. Pharmaceutical reimbursement: an overview.
Johnson PE
Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S4-10. PubMed ID: 18192246
[TBL] [Abstract][Full Text] [Related]
38. Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing.
Gitlin M; Wilson L
Am J Ind Med; 2007 Apr; 50(4):303-15. PubMed ID: 17370319
[TBL] [Abstract][Full Text] [Related]
39. Fresh Approaches to Addressing High Drug Costs.
Armstrong J; Becker C
NCSL Legisbrief; 2019 Apr; 27(15):1-2. PubMed ID: 30990598
[No Abstract] [Full Text] [Related]
40. Third party payment policies: design & impact.
Schondelmeyer SW
Am Pharm; 1986 Aug; NS26(8):41-5, 48-56, 63-8. PubMed ID: 3776831
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
